Impact of Hospitalization on High-sensitivity Cardiac Troponin T Concentrations Depending on Disease Severity
NCT ID: NCT04963400
Last Updated: 2024-04-03
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
177 participants
OBSERVATIONAL
2021-07-14
2024-01-17
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prognostic Relevance of High-sensitivity Troponin in Patients With Acute Decompensated Heart Failure
NCT01429857
Exercise-induced High-sensitivity Troponin Levels as a Predictor for Obstructive Coronary Artery Disease
NCT02626806
The Impact of Routine Measurement of Cardiac Troponin (hsTnT) on Outcome in Elderly Patients Undergoing Major Surgery
NCT03605134
Diagnostic Evaluation of Out-of-hospital High-sensitivity Troponin I in Patients Presenting Chest Pain
NCT04950244
Quantification and Description of the Increase in Serum Troponin Following Acute Coronary Syndrome
NCT01698021
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with low disease severity
Hospitalized patients without a diagnosed or suspected cardiac disease and with an acute medical condition of low severity (e.g. patients with retinal detachment)
Analysis of hs-cTnT serum concentration at hospitalization
Analysis of the hs-cTnT serum concentration in the blood drawn at the day of hospitalization
Analysis of hs-cTnT serum concentration after discharge
Analysis of the hs-cTnT serum concentration in the blood drawn after discharge (60 days after hospitalization)
Patients with medium disease severity
Hospitalized patients without a diagnosed or suspected cardiac disease and with an acute medical condition of medium severity (e.g. patients with an uncomplicated acute pancreatitis oder an acute exacerbation of a chronic inflammatory bowel disease)
Analysis of hs-cTnT serum concentration at hospitalization
Analysis of the hs-cTnT serum concentration in the blood drawn at the day of hospitalization
Analysis of hs-cTnT serum concentration after discharge
Analysis of the hs-cTnT serum concentration in the blood drawn after discharge (60 days after hospitalization)
Patients with high disease severity
Hospitalized patients without a diagnosed or suspected cardiac disease and with an acute medical condition of high severity (e.g. patients with a proximal femoral fracture)
Analysis of hs-cTnT serum concentration at hospitalization
Analysis of the hs-cTnT serum concentration in the blood drawn at the day of hospitalization
Analysis of hs-cTnT serum concentration after discharge
Analysis of the hs-cTnT serum concentration in the blood drawn after discharge (60 days after hospitalization)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Analysis of hs-cTnT serum concentration at hospitalization
Analysis of the hs-cTnT serum concentration in the blood drawn at the day of hospitalization
Analysis of hs-cTnT serum concentration after discharge
Analysis of the hs-cTnT serum concentration in the blood drawn after discharge (60 days after hospitalization)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* age ≥ 50 years
Exclusion Criteria
* acute medical conditions commonly associated with a myocardial injury (e.g. circulatory shock, sepsis, pulmonary embolism, cerebral infarction, acute renal failure)
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Leipzig
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rolf Wachter
Professor MD
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Leipzig Medical Center
Leipzig, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RL_2021_1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.